Bone Biologics (BBLG) Shares Outstanding (2010 - 2025)

Bone Biologics (BBLG) has 16 years of Shares Outstanding data on file, last reported at $1.8 million in Q4 2025.

• Shares Outstanding for Q4 2025 came in at $1.8 million, up 264.58% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.8 million (up 264.58% YoY), and the FY2025 annual result was $1.8 million, up 264.58% from the prior year.
• Shares Outstanding steadied at $1.8 million in Q4 2025 per BBLG's latest filing, from $1.8 million in the prior quarter.
• Over five years, Shares Outstanding peaked at $12.3 million in Q1 2021 and troughed at $43189.0 in Q4 2021.
• A 5-year average of $3.8 million and a median of $518838.5 in 2024 frame the typical range for Shares Outstanding.
• The sharpest annual moves came in 2021 and 2025: Shares Outstanding tumbled 99.65% in 2021, then soared 668.35% in 2025.
• A 5-year view of Shares Outstanding shows it stood at $43189.0 in 2021, then jumped by 47.77% to $63820.0 in 2022, then surged by 39.65% to $89127.0 in 2023, then soared by 452.49% to $492417.0 in 2024, then surged by 264.58% to $1.8 million in 2025.
• Business Quant data shows BBLG's Shares Outstanding at $1.8 million in Q4 2025, $1.8 million in Q3 2025, and $1.7 million in Q2 2025.